Bipolar Disorder Clinical Trials 2024 (Updates): FDA Approvals, Drugs, Medication, Pipeline, Treatment Market, and Companies by DelveInsight

(Albany, USA) DelveInsight's, "Bipolar Disorder Pipeline Insight 2024" report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Bipolar Disorder Pipeline Report
• DelveInsight's Bipolar Disorder pipeline report depicts a robust space with 22+ active players working to develop 22+ pipeline therapies for Bipolar Disorder treatment.
• The leading companies working in the Bipolar Disorder Market include Vanda Pharmaceuticals, Reviva Pharmaceuticals, SK BIOPHARMACEUTICALS, Pear Therapeutics, Arvelle Therapeutics, Janssen Research & Development, Sunovion Pharmaceuticals, Lyndra Therapeutics, ILTOO Pharma, COMPASS Pathways, NRx Pharmaceuticals, Carlsson Research AB, Sunovion, SAGE Therapeutics, Alzamend Neuro, OWP Pharmaceuticals, Entheogenix Biosciences, and others.
• Promising Bipolar Disorder Pipeline Therapies in the various stages of development include Risperdal Consta, Seroquel IR 300mg, Quetiapine Formulation A 300mg, Sublingual film containing Dexmedetomidine (BXCL501), and others.
• March 2024: Janssen Pharmaceutica N.V., Belgium announced a study of Phase 2 clinical trials for JNJ-55308942. The purpose of this study is to evaluate the efficacy of JNJ-55308942 compared to placebo on symptoms of depression in participants with bipolar disorder (BD) in a major depressive episode (MDE) at Week 6.

Request a sample and discover the recent advances in Bipolar Disorder Treatment Drugs @ Bipolar Disorder Pipeline Report- https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

In the Bipolar Disorder pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, Bipolar Disorder clinical trials studies, NDA approvals (if any), and product development activities comprising the technology, Bipolar Disorder collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Bipolar Disorder Overview
Bipolar disorder is a mental health condition characterized by extreme mood swings, including emotional highs (mania or hypomania) and lows (depression). These mood swings can significantly impact a person's energy, activity levels, behavior, and ability to carry out daily tasks.
During a manic episode, individuals may feel euphoric, overly energetic, or unusually irritable. They may engage in risky behaviors, experience racing thoughts, have inflated self-esteem, and sleep less. Hypomania is a less severe form of mania, where symptoms are noticeable but not as disruptive.
In contrast, depressive episodes involve feelings of sadness, hopelessness, and loss of interest in most activities. Individuals may experience changes in appetite, sleep disturbances, fatigue, difficulty concentrating, and thoughts of death or suicide.
Bipolar disorder is divided into several types, with Bipolar I and Bipolar II being the most common. Bipolar I involves severe manic episodes lasting at least seven days or requiring hospitalization, often alternating with depressive episodes. Bipolar II involves a pattern of depressive episodes and hypomanic episodes, but not the full-blown manic episodes seen in Bipolar I.
The exact cause of bipolar disorder is unknown but involves a combination of genetic, biochemical, and environmental factors. Treatment typically includes mood stabilizers, antipsychotic medications, antidepressants, and psychotherapy. Effective management enables many individuals with bipolar disorder to lead productive and fulfilling lives, though ongoing treatment is usually necessary to prevent relapse.

Find out more about Bipolar Disorder Therapeutics Assessment @ Bipolar Disorder Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Bipolar Disorder Emerging Drugs Profile
• Iloperidone: Vanda Pharmaceuticals
• RP5063: Reviva Pharmaceuticals

Bipolar Disorder Pipeline Therapeutics Assessment
There are approx. 22+ key companies which are developing the Bipolar Disorder therapies. The Bipolar Disorder companies which have their Bipolar Disorder drug candidates in the most advanced stage, i.e. phase III include, Vanda Pharmaceuticals.

Learn more about the emerging Bipolar Disorder Pipeline Therapies @ Bipolar Disorder Clinical Trials Assessment- https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Bipolar Disorder Pipeline Report
• Coverage- Global
• Bipolar Disorder Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Bipolar Disorder Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Bipolar Disorder Companies- Vanda Pharmaceuticals, Reviva Pharmaceuticals, SK BIOPHARMACEUTICALS, Pear Therapeutics, Arvelle Therapeutics, Janssen Research & Development, Sunovion Pharmaceuticals, Lyndra Therapeutics, ILTOO Pharma, COMPASS Pathways, NRx Pharmaceuticals, Carlsson Research AB, Sunovion, SAGE Therapeutics, Alzamend Neuro, OWP Pharmaceuticals, Entheogenix Biosciences, and others.
• Bipolar Disorder Pipeline Therapies- Risperdal Consta, Seroquel IR 300mg, Quetiapine Formulation A 300mg, Sublingual film containing Dexmedetomidine (BXCL501), and others.

Dive deep into rich insights for new drugs for Bipolar Disorder treatment, Visit @ Bipolar Disorder Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
1. Introduction
2. Executive Summary
3. Bipolar Disorder: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Bipolar Disorder - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Iloperidone: Vanda Pharmaceuticals
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. OSU6162: Carlsson Research AB
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. RP5063: Reviva Pharmaceuticals
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Research programme: small molecule therapeutics: Entheogenix Biosciences
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Bipolar Disorder Key Companies
21. Bipolar Disorder Key Products
22. Bipolar Disorder- Unmet Needs
23. Bipolar Disorder- Market Drivers and Barriers
24. Bipolar Disorder- Future Perspectives and Conclusion
25. Bipolar Disorder Analyst Views
26. Bipolar Disorder Key Companies
27. Appendix

For further information on the Bipolar Disorder Pipeline therapeutics, reach out to Bipolar Disorder Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• 3d Cardiac Mapping System Market: https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market
• Acute Radiation Syndrome Market: https://www.delveinsight.com/report-store/acute-radiation-syndrome-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Alagille Syndrome Market: https://www.delveinsight.com/report-store/alagille-syndrome-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Brain Aneurysm Stents Market: https://www.delveinsight.com/report-store/brain-aneurysm-stents-market
• Chronic Bronchitis Market: https://www.delveinsight.com/report-store/chronic-bronchitis-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelocytic-leukemia-cml-market
• Chronic Progressive Multiple Sclerosis Market: https://www.delveinsight.com/report-store/chronic-progressive-multiple-sclerosis-market
• Cutaneous Lupus Erythematosus Market: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market
• Encephalitis Market: https://www.delveinsight.com/report-store/encephalitis-market
• Refractory Chronic Cough Market: https://www.delveinsight.com/report-store/chronic-refractory-cough-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Aicardi-goutières Syndrome Market: https://www.delveinsight.com/report-store/aicardi-goutieres-syndrome-market
• Anemia In Ckd Market: https://www.delveinsight.com/report-store/anemia-in-chronic-kidney-disease-market
• Anovulation Market: https://www.delveinsight.com/report-store/anovulation-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Artificial Iris Market: https://www.delveinsight.com/report-store/artificial-iris-market
• Athlete's Foot Market: https://www.delveinsight.com/report-store/athletes-foot-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Bacteremia Market: https://www.delveinsight.com/report-store/bacteremia-market
• Biliary Atresia Market: https://www.delveinsight.com/report-store/biliary-atresia-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Brain Cancer Market: https://www.delveinsight.com/report-store/brain-cancer-market
• Bunion Market: https://www.delveinsight.com/report-store/bunion-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/neuroendocrine-tumors-market
• Cardiac Insufficiency Market: https://www.delveinsight.com/report-store/congestive-heart-failure-market
• Cardiac Resynchronization Therapy Device Market: https://www.delveinsight.com/report-store/cardiac-resynchronization-therapy-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
• Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast
• Chronic Refractory Cough Market: https://www.delveinsight.com/report-store/chronic-refractory-cough-market
• Diffuse Large B-cell Lymphoma Market: https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
• Egfr Non-small Cell Lung Cancer Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market
• Endometriosis Pain Market: https://www.delveinsight.com/report-store/endometriosis-pain-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.